Impax Asset Management Group plc
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1749768
LONDON, X0
Position in VRTX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,845,996
-$249,433 QoQ
Shares Held
4,134
-10.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Impax Asset Management Group plc holds $78,417,640 across 7 Biotechnology names. VRTX ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
152,444 | $30,435,444 | |
| 2 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
350,000 | $12,712,000 | |
| 3 | TECH |
BIO-TECHNE Corp
|
195,000 | $10,190,700 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
300,000 | $8,310,000 | |
| 5 | CYTK |
Cytokinetics Inc
|
125,000 | $8,238,750 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
225,000 | $6,684,750 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
4,134 | $1,845,996 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,845,996 | 4,134 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $2,095,429 | 4,622 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $1,810,160 | 4,622 | Shares | Defined | 2025-11-06 | |
| 2025-06-30 | $2,057,714 | 4,622 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $3,393,255 | 6,999 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $2,788,294 | 6,924 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $3,456,939 | 7,433 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $25,027,773 | 53,396 | Shares | Defined | 2024-11-08 | |
| 2024-03-31 | $28,323,521 | 67,758 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $34,306,116 | 84,313 | Shares | Defined | 2024-01-26 | |
| 2023-09-30 | $194,086,908 | 558,138 | Shares | Defined | 2023-11-07 | |
| 2023-06-30 | $205,487,287 | 583,920 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $240,192,669 | 762,347 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $220,631,096 | 764,011 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $202,021,612 | 697,733 | Shares | Defined | 2022-11-08 | |
| 2022-06-30 | $203,151,991 | 720,934 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $224,609,571 | 860,672 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $226,814,958 | 1,032,855 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $194,946,363 | 1,074,736 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $152,336,909 | 755,527 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $19,118,333 | 88,968 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $17,860,686 | 75,572 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $17,739,774 | 65,191 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $13,513,930 | 46,550 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $12,533,064 | 52,671 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||